GHK-Cu 50mg Peptide
In stock
GHK-Cu 50mg is supplied in a research vial of the copper(II)-bound tripeptide glycyl-L-histidyl-L-lysine. Its research profile includes collagen synthesis, extracellular-matrix remodelling and formulation-specific skin studies.
GHK-Cu and extracellular-matrix biology
GHK-Cu 50mg combines the tripeptide GHK with copper(II). Also known as copper tripeptide-1, the complex has attracted sustained interest in the cellular processes that build and remodel connective tissue.
Collagen and tissue-remodelling studies
Fibroblast experiments have reported increased collagen synthesis following GHK-Cu exposure. In rat wound chambers, researchers also measured greater accumulation of collagen and other matrix components. These results provide an experimental foundation for investigating how copper-peptide signalling relates to tissue repair.
More recent studies have examined GHK-Cu alongside hyaluronic acid in fibroblasts and excised skin. Such work explores whether formulation and ingredient combinations influence specific collagen responses, including collagen IV associated with the skin's structural organisation.
Skin research and formulation
Clinical skin investigations include particular topical preparations, sometimes combining GHK-Cu with other ingredients. Their findings are relevant to the preparations tested and complement the laboratory evidence, rather than establishing the same effect for every presentation.
This 50mg research listing is best understood through copper-peptide chemistry and matrix biology. Copper-free GHK, other copper mixtures and finished topical products have distinct identities or formulations, so their results should be matched carefully to the material studied.
Also known as / branded as
- Copper tripeptide-1
- GHK-copper complex
- Copper peptide GHK
- Cu-GHK
- Glycyl-L-histidyl-L-lysine-copper(II)
| Dynamic Performance Range | Dynamic Performance: Peptides |
|---|








